Spring direct naar de hoofdnavigatie of de inhoud

Life Sciences

In life sciences, including biotechnology, V.O. represents clients in a broad range of traditional pharmaceutical as well as biological technologies, including immunology, virology, molecular biology, animal and plant genetics, gene therapy, protein chemistry, pharmacology, enzymology, bioinformatics and others. Specific areas of expertise include among others diagnostics, recombinant cytokines, antibody technology, personalized medicine, biomarkers, recombinant antigens and vaccines, and antisense and small RNA technology.

From start-ups to multinationals

Our client base in the life sciences and biotechnology sector ranges from biotech start-ups to multinationals. Working for and with biotech start-ups requires a special approach, as balancing research and commercial development may be complex. The long-term IP strategy, for instance, in which the patent portfolio should be attractive to possible investors and licensees, sometimes seems at odds with the short-term company policy. We know exactly how to provide solutions that are workable and effective.

Renowned experts

Our patent attorneys include renowned experts in biotech and life sciences. Some have worked in the life sciences industry, for instance as researcher. All of them are highly dedicated to their profession, and see it as their mission to help companies to build up a sound and balanced IP portfolio that enables these companies to keep up the good work.

Full-service partner

We provide all IP services: drafting and prosecuting patent applications all over the world. We assist you in defending or attacking patents; in infringement suits and in opposition or invalidity proceedings. Other fields of activity are Freedom To Operate analysis, IP audits and Supplementary Protection Certificates for pharmaceuticals and agrochemicals. Particularly for biotech start-ups we commit ourselves to supporting you throughout the different developmental stages of your company. We help you to integrate IP into your operational management and materialize the knowledge assets of your company.

Contact our experts

Jetze Beeksma

Jetze Beeksma

  • European and Dutch Patent Attorney
  • Senior Associate
More experts

News

Individual accreditations by MIP

After IP Stars, the annual guide from Managing IP (MIP), already recognized our Dutch and Belgian patent practices as ‘Tier 1’ and ‘Tier 2’ Patent Prosecution Firms, respectively, individual distinctions of ‘IP Star 2021’ were awarded in the Fall to Bettina Hermann, Leo Jessen, Bernard Ledeboer, Marco Molling, Otto Oudshoorn and Herman Witmans.Continue reading

In V.O.’s lab: spotlight on the patent attorney

Patent attorneys administer a key amount of the intellectual property — the crown jewels — of your business. Each one is a versatile technician who is expected to be a ‘Jack of all trades.’ What makes a good patent attorney at V.O.? Here follows a character sketch.Continue reading

Events in the time of corona  

Various IP trade fairs, congresses, and conferences, which were already deferred in 2020 to 2021 due to corona, have now been deferred again to next year. It’s an annoying fact but one we must continue to consider for the time being.Continue reading

Events

Business Days Twente 2022

University of Twente, Drienerlolaan, Enschede, Netherlands

Business Days Twente 2022  consists of a series of events aimed at creating and improving contacts between students, post-graduates and alumni on one side, and potential employers on the other. Continue reading

EPO Tech Day 2022: Technologies of Transformation

Tech Day is an annual celebration of innovation, learning and collaboration that takes place at the European Patent Office (EPO). Primarily an internal event until now, Tech Day brings together teams of experts from across the Office to explore a technological theme of special significance. Continue reading

IPBC Europe 2022

The Landmark London, Marylebone Road, London, UK

Europe’s foremost conference on IP value creation, organized by IAM. The event will bring together elite decision makers to discuss key policy, business and legal developments, as well as the best strategies for maximising IP value in the increasingly dynamic European market. Continue reading